Home540596 • BOM
add
Eris Lifesciences Ltd
Previous close
₹1,365.95
Day range
₹1,362.70 - ₹1,393.90
Year range
₹810.10 - ₹1,521.05
Market cap
187.39B INR
Avg Volume
3.64K
P/E ratio
53.93
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 7.39B | 47.64% |
Operating expense | 3.69B | 38.14% |
Net income | 915.90M | -25.80% |
Net profit margin | 12.39 | -49.76% |
Earnings per share | 6.72 | -25.83% |
EBITDA | 2.62B | 45.25% |
Effective tax rate | 25.37% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.43B | 27.24% |
Total assets | 70.22B | 81.20% |
Total liabilities | 38.45B | 165.59% |
Total equity | 31.77B | — |
Shares outstanding | 136.09M | — |
Price to book | 6.71 | — |
Return on assets | — | — |
Return on capital | 7.72% | — |
Cash Flow
Net change in cash
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 915.90M | -25.80% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,620